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Abstract
According to the National Multiple Sclerosis (MS) Society, MS, a demyelinating
brain disease, affects approximately 2.3 million people worldwide. MS affects AfricanAmericans, Asians and Hispanics, but predominantly Caucasians of northern European
ancestry. Women are three times more likely to be diagnosed with this disease, and
individuals from populations with low vitamin D levels are more likely as well to develop
the disease. Currently, there is no cure for MS, although some moderately effective
treatments are available to slow some forms of disease progression. However, our
understanding of the cause of MS, which would greatly facilitate treatment, remains very
incomplete. One clue may be found in the presence of circulating antibodies to a brain
protein, aquaporin-4, in the serum of patient with a form of MS, neuromyelitis optica,
which affects chiefly the spinal cord and optic nerves. In this study,
immunohistochemistry was used to determine abnormalities of this and a related protein,
aquaporin 1, in brain tissues of deceased patients who were diagnosed with MS in
comparison to control patients with normal brain tissues. Although MS affects mostly
white matter, we found increased expression of aquaporin-1 in gray matter in the vicinity
of demyelinated plaques in patients with MS compared to unaffected areas of brain in
both MS and control patients. In contrast, expression of aquaporin-4 was relatively
unchanged in these areas. We determined that increased aquaporin-1 expression was due
to a change in the phenotype of astrocytes, a support cell of the brain, in the cerebral
cortex in and near demyelinated areas in MS. This change in astrocytes may underlie
some of the brain dysfunction observed in patients with MS.

I.

Introduction
Neuromyelitis optica (NO) is a specific type of multiple sclerosis (MS) that

targets the spinal cord and the optic nerve, resulting in impaired vision (Lennon, 2004). It
is common to misdiagnose NO as multiple sclerosis; however, specific treatments for NO
exist and show some efficacy (2004). In general, MS results from damaged or loss of
myelin due to an immune attack on oligodendroglia, the myelin-producing cells of the
brain (Okahara, 2014) that are found chiefly in the white matter, the major component of
the deeper (noncortical) regions of brain tissue. This damage occurs in a patchy
distribution, with demyelinated lesions commonly referred to as “plaques.” Hence, MS
has been primarily considered a white matter disease. However, especially the deeper
layers of the cerebral cortex contain lightly myelinated axons, and MS can affect these
regions as well. Moreover, the inflammatory cells (macrophages and lymphocytes) that
are found in demyelinated white matter plaques of MS may also extend into the cortex
and be associated with loss of myelin there.
Aquaporin channels found in a variety of sites in the body, and serve as
specialized structures that transport water across a membrane. Aquaporin-4 is the major
protein in the central nervous system that permits water flow, and is found mainly in
processes of astrocytes. Aquaporins regulate both normal water flow and in response to
stress or injuries (Binder, 2013). As a result, a change in aquaporin-4 pathology is likely
to result from various brain diseases. Aquaporin-1 plays an important role in water
homeostasis in the brain after a traumatic brain injury; these can also function as a CO2
transporter as well (Young, 2010). A role for aquaporin-1 and -4 in the development of
MS and especially NO has been suggested by recent evidence that autoreactive antibodies

to both of these proteins are found in the serum of patients with demyelinating diseases
(Tzartos, 2013). Based on these observations, we undertook a study of changes in
aquaporin-1 and -4 expression in the brain tissue of patients with MS. We found the
most striking changes to occur in aquaporin-1 in affected cortical regions in and near
multiple sclerosis plaques. This discovery suggests that changes in aquaporin-expressing
astrocytes in gray matter are a previously unrecognized feature of MS that may contribute
to tissue dysfunction and symptoms in the disease.

II.

Literature Review
Multiple sclerosis (MS) is an inflammatory disease that affects more than 2.1

million people worldwide, most commonly appearing in individuals ranging from ages
20-40 years old. While some scientists try to pin this disease on toxins, viruses and even
food, very little is known about the causes of multiple sclerosis. However, patterns such
as age, gender, and environmental factors can increase an individual’s chances of
developing the disease. Treatment often includes antiviral drugs such as beta-interferon,
which is effective in decreasing the number of attacks and slowing down progression of
the disease. Many patients, however, do not endure therapy since the drugs typically
prescribed for MS have severe side effects (NMSS, n.d.).
Currently, multiple sclerosis is classified as a white matter disease. The bundles
of axons that make up the white matter in the brain are normally covered in myelin. This
white insulating fatty layer of myelin is destroyed in individuals with multiple sclerosis,
causing axons to be left exposed and less capable of electrical signal conduction. This

characteristic of multiple sclerosis results in a loss of senses and problems with motor
coordination (Wegner, 2009).
While researchers initially looked more at the effects of multiple sclerosis on
white matter and how parts of the brain work together, focus has recently shifted to the
effects on the gray matter and how this disease affects thinking and learning over time.
Little research has been done on the impact of gray matter in multiple sclerosis due to the
ease of studying white matter, where lesions are most commonly found and are obvious
as areas of white matter discoloration. Scientists are able to observe degradation in
myelin of multiple sclerosis patients by examining samples under a microscope and
identifying pathologic features such as demyelination, the presence of inflammatory cells,
and, in severe disease, axonal damage. However, there is growing appreciation for
involvement of gray matter as well, that over time may cause functional losses manifest
as loss of cognitive function (Binder, 2013).
I am interested in exploring this topic because since working in a neuropathology
lab, I get the opportunity to observe different pathology of various brain diseases. By
looking at the pathology of an individual’s brain, one can make a fairly good prediction
about a patient’s symptoms and vice versa. By determining whether or not MS has an
effect on the gray matter cortical region of the brain, new treatments can be discovered to
improve cognitive outcomes in patients with long-standing disease. In addition, I am
interested in promoting a broader consideration of the effects of MS on both white and
gray matter in the brain and the implications of discoveries in this area on understanding
the root causes and consequences of MS.

III.

Methods
Brain tissue from patients who had died with MS was obtained by the Oregon

Brain Bank after consent was obtained from the next of kin to the deceased. Tissues were
fixed for at least 10 days in neutral buffered formalin, dissected, and demyelinated
plaques were grossly identified. Affected areas were embedded into paraffin cassette
blocks. The blocks were then cut 7 micrometer thick, applied to a microscope slide, and
left overnight to dry. Using a modification of the Abcam immunohistochemistry protocol.
20 different, variably affected brain regions from different patients were stained using
immunohistochemistry for aquaporin-1 and -4, as described in more detail below.
On the first day, the slides were placed into a 600 Celsius oven for one hour to
melt the paraffin, and then put into 6 washes of xylenes, and 2 washes of ethanol to
remove the rest of the paraffin and permit tissue proteins to be exposed to solutions
subsequently. The slides were then placed into 95% formic acid solution for five minutes
to further enhance tissue protein exposure, then transferred to running water for another
five minutes to wash off remaining formic acid. Afterwards, the slides were set into citric
acid buffer that was already warmed and heated water bath for 45 minutes so that tissue
antigens could be recovered. The slides were taken out to cool for then minutes, then
dipped ten times in cold water before placing in phosphate buffer saline (PBS) for five
minutes. They were then transferred into a 3% milk PBS solution for ten minutes to allow
for blocking to prevent non-specific antibody binding. Antibodies dilutions were made in
3% milk PBS solutions; anti-aquaporin-1 was diluted 1:500 and anti-aquaporin-4 was
diluted to 1:1000 according to previous determinations of optimal binding and signal

generation. The dilutions were applied on each designated slide and allowed to incubate
in 00 C overnight for the antibodies to reach equilibrium binding to proteins in the tissues.
The next day the slides were taken out, washed in PBS, and then placed back into
3% milk in PBS blocking solution. Anti-rabbit secondary antibody solution was prepared
in 3% milk in PBS. Secondary antibody solutions were made at a concentration of 1:200
dilution of the manufacturer’s stock solution. The secondary antibody was applied on the
slides and left to incubate in room temperature for one hour. After the incubation, the
slides were first taken out and washed in water, and then in a methanol wash for 10
minutes. The methanol wash was prepared using 8 parts anhydrous methanol, 1 part
hydrogen peroxide, and 1 part distilled, deionized water to quench endogenous tissue
peroxidases. The slides were then briefly put into water for rehydration and 2 washes of
PBS each for two minutes. Meanwhile, a developing solution was made using the
standard developer for diaminobenzidine (DAB) brown staining. 50-microliters drops of
each A and B solutions in the Vector Laboraties Elite developer kit were used per 5
milliliters of PBS. The developer was then applied on the slides and left to incubate at
room temperature for one hour. Afterwards, the slides were taken out and washed with
PBS. The brown stain was then made using DAB tablets dissolved in PBS; for every
tablet used, 20mL of PBS was used to dissolve it, and 40 microliter of hydrogen peroxide
was used to activate the enzymatic activity. The brown developer solution was then
applied to the slides and left to incubate for 10 minutes while precipitate formed in areas
of aquaporin content. The slides were then washed in water and then put into an
automatic stainer to counter stain-using hemotoxylin & eosin. Coverslips were applied on

the slides using glue and finally, each slide was evaluated under the microscope while
observations were made and recorded with a Leica microscope camera.
The same cases had a replicated set of slides cut and stained in hematoxalin and
eosin (H&E). They were first baked in a 60-degree oven and then depariffinized and then
went into an automatic stainer for counter-staining and then were stained with Luxol fast
blue (LFB) myelin stain. These slides were then cover slipped and ultimately used to
complement the observations that resulted from the immunohistochemistry stains and to
compare these with the presence of demyelinating lesions.
IV. Results
H&E/LFB-stained sections were examined to identify the presence of
demyelinated plaques, inflammatory cells, and other morphologic features of MS brain
tissue. Subsequently, immunohistochemically stained sections were evaluated and the
presence of aquaporin-1 and -4 were correlated with other tissue features. We found that
normal white matter contained abundant aquaporin-1 and -4 and that these were only
modestly decreased in areas of MS plaques (Figure 1). Normal cortex also contained
abundant aquaporin-4 and this was not significantly decreased in gray matter affected by
MS lesions (Figure 2). The most striking disease-associated changes were found in
cerebral cortical expression of aquaporin-1, which was markedly increased in gray matter
affected by MS, but essentially absent in normal cortex. Similarly, in control brains of
individuals without multiple sclerosis, the cortical region of the brain showed little to no
aquaporin-1 protein.
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Figure 1. Representative hematoxalin- and eosin-stained sections of human brain tissue
affected by multiple sclerosis, with luxol fast blue stain for myelin. (A) Normal cerebral
cortex from an area unaffected by MS, showing lightly myelinated axons stained blue
(arrows) in a background of intact neurons and glial cells. Larger dark blue structures are
blood vessels that contain red blood cells that also are stained by this technique. (B)
Cerebral cortex in the area of a demyelinated plaque, with scant myelinated axons with a
beaded degenerating morphology (arrow). (C) Normal subcortical white matter, which is
more richly and diffusely myelinated. (D) White matter in a demyelinated MS plaque,
showing an absence of axonal myelin; residual blood vessels are the only blue-staining
structures.
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Figure 2. Aquaporin-1 expression in MS as determined by immunohistochemical
staining of brain tissue sections with development of signal as brown color and
hematoxalin (light blue) nuclear counterstain. Representative areas are depicted. (A)
Normal cortex showing neurons and glial cells without significant aquaporin-1
expression. (B) Cortex in an area of demyelination, with astrocyte expression of
abnormally high levels of aquaporin-1 in their processes. (C) Normal white matter, with
abundant aquaporin-1 expression in glial cells. (D) Demyelinated white matter in an MS
plaque, with modest depletion of aquaporin-1 along with other normal white matter
components.
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Figure 3. Aquaporin-4 expression in MS as determined by immunohistochemical
staining of brain tissue sections with development of signal as brown color and
hematoxalin (light blue) nuclear counterstain. Representative areas are depicted. (A)
Normal cortex showing aquaporin-4 expression by astrocytes in their processes. (B)
Cortex in an area of demyelination, with relatively normal distribution of astrocyte
expression of abnormally high levels of aquaporin-4. (C) Normal white matter, with
abundant aquaporin-4 expression in glial cells. (D) Demyelinated white matter in an MS
plaque, with a subtly more course pattern of aquaporin-4 expression.

V. Discussion
Based on my research, the assumption that multiple sclerosis only affects the
white matter in the brain conflicts with the findings that there are pathological changes in
the aquaporin-1 protein distribution in the gray matter cortical region in areas near white
matter plaques and especially in areas in which tissue damage including inflammatory
lesions is adjacent or extends to involve the cerebral cortex. In comparison with control

brains, individuals affected with multiple sclerosis showed increased expression of
aquaporin-1 proteins in these affected cortical region of their brains. This is the gray
matter of the brain, and could be an explanation to why some individuals with MS
demonstrates demented symptoms such as obsession, compulsion, interpersonal
sensitivity, anger–hostility, phobic anxiety, paranoid ideation, psychoticism (Sarısoy,
n.d.). Although there were changes of aquaporin-1 in the cortical region of the brain, this
is not a specific marker for multiple sclerosis based on our observation of similar changes
in this protein in other brain diseases (data not shown). However, its expression is a
convenient way to identify and map affected cerebral cortical tissue in MS. As noted
previously, the presence of autoantibodies against aquaporin-1 or -4, currently serve as a
potential helpful marker for chronic demyelinated diseases such as NO (Tzartos, 2013).
An interesting application of this finding could be to compare the IHC stains of
aquaporin-1 & 4 with MRI images to determine the scanning parameters. Those scanning
parameters, when precisely determined, could be used to optimize scans in living
individuals for a more precise diagnosis of multiple sclerosis. More fundamentally, we
have identified a novel change in astrocyte phenotype that correlates with cortical
damage in MS. Studies of the functional consequences of this change may inform us
about additional and unanticipated ways in which MS affected the brain, and point to new
disease therapies.
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